GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Cyclically Adjusted FCF per Share

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Cyclically Adjusted FCF per Share : ¥0.40 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Jiangsu Hengrui Pharmaceuticals Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥0.106. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.40 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Jiangsu Hengrui Pharmaceuticals Co's average Cyclically Adjusted FCF Growth Rate was 29.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 15.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 24.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Jiangsu Hengrui Pharmaceuticals Co was 44.20% per year. The lowest was 10.50% per year. And the median was 26.00% per year.

As of today (2024-05-08), Jiangsu Hengrui Pharmaceuticals Co's current stock price is ¥46.96. Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.40. Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF of today is 117.40.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Jiangsu Hengrui Pharmaceuticals Co was 336.96. The lowest was 91.69. And the median was 180.46.


Jiangsu Hengrui Pharmaceuticals Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Cyclically Adjusted FCF per Share Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.28 0.33 0.31 0.39

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.33 0.35 0.39 0.40

Competitive Comparison of Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF falls into.



Jiangsu Hengrui Pharmaceuticals Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jiangsu Hengrui Pharmaceuticals Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.106/114.6694*114.6694
=0.106

Current CPI (Mar. 2024) = 114.6694.

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.071 98.200 0.083
201409 0.045 98.900 0.052
201412 0.055 99.000 0.064
201503 0.060 99.900 0.069
201506 0.092 99.500 0.106
201509 0.059 100.500 0.067
201512 0.086 100.600 0.098
201603 0.059 102.200 0.066
201606 0.075 101.400 0.085
201609 0.064 102.400 0.072
201612 0.037 102.600 0.041
201703 0.071 103.200 0.079
201706 0.086 103.100 0.096
201709 0.111 104.100 0.122
201712 0.072 104.500 0.079
201803 0.052 105.300 0.057
201806 0.127 104.900 0.139
201809 0.092 106.600 0.099
201812 0.082 106.500 0.088
201903 0.056 107.700 0.060
201906 0.148 107.700 0.158
201909 0.155 109.800 0.162
201912 0.149 111.200 0.154
202003 0.273 112.300 0.279
202006 0.270 110.400 0.280
202009 0.060 111.700 0.062
202012 -0.115 111.500 -0.118
202103 -0.015 112.662 -0.015
202106 0.141 111.769 0.145
202109 0.217 112.215 0.222
202112 0.060 113.108 0.061
202203 -0.085 114.335 -0.085
202206 -0.013 114.558 -0.013
202209 0.208 115.339 0.207
202212 -0.210 115.116 -0.209
202303 -0.026 115.116 -0.026
202306 0.327 114.558 0.327
202309 0.171 115.339 0.170
202312 0.506 114.669 0.506
202403 0.106 114.669 0.106

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Jiangsu Hengrui Pharmaceuticals Co  (SHSE:600276) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=46.96/0.4
=117.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Jiangsu Hengrui Pharmaceuticals Co was 336.96. The lowest was 91.69. And the median was 180.46.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Jiangsu Hengrui Pharmaceuticals Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Traded in Other Exchanges
N/A
Address
No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines